Cardiorespiratory fitness of healthy Polish men and women with various somatotypes Authors: Anna Lipowicz, Aleksandra Pol, Karolina Świerczyńska, Andrzej Knapik, Zbigniew Nowak, Andrzej Myśliwiec, Katarzyna Nierwińska Published: 2025 ABSTRACT BackgroundCardiorespiratory fitness (CRF), assessed by maximal oxygen uptake (VO₂max), is one of the strongest indicators of cardiovascular health and overall risk of death. Somatotype provides a comprehensive description of the morphological constitution of the body, but is seldom used in the context of health or chronic disease risk assessment. The present study aimed to assess the relationship between CRF and somatotype in healthy adult Polish men and women.Materials and methodsThe study included 276 subjects (146 men and 130 women) aged 18–72 years. Anthropometric measurements were performed using the Martin and Saller method, and the somatotype was determined using the Heath-Carter modification of Sheldon’s typology. The three main components of body composition assessed were endomorphy, mesomorphy, and ectomorphy. In addition, aerobic capacity was estimated using the Astrand-Ryhming test, with blood pressure and heart rate monitored at rest, and the latter also recorded during exercise. Statistical analyses were performed using the Kruskal-Wallis test, Mann-Whitney test and Pearson’s correlation.ResultsThe mesomorphic somatotype was the most common among men, while the endomorphic somatotype predominated among women. Somatotype differentiated body mass index (BMI, kg/m2), waist circumference, and waist-to-hip ratio (WHR), with ectomorphic subjects having the lowest values for these parameters. The highest systolic and diastolic blood pressure measures were found in endomorphic subjects, especially in the female group (respectively, H = 9.3, p = 0.009 and 9.0, p = 0.011). In men, the results of the Astrand-Ryhming test showed that mesomorphs had the highest VO₂max (ml/kg/min and l/min), and ectomorphs the lowest (H = 7.6, p = 0.022 and H = 10.1, p = 0.006, respectively for both units). In women, differences in VO₂max between somatotypes were smaller, though still present. Negative correlations were observed between VO₂max, expressed in ml/kg/min, and the endomorphic component, while positive correlations were observed between VO₂max (l/min) and mesomorphy.ConclusionsSomatotype significantly differentiates anthropometric parameters and CRF in adults. Mesomorphy favours higher aerobic capacity, while endomorphy is associated with less favourable blood pressure values and lower VO₂max. These findings highlight the potential value of somatotype as a complementary tool for assessing health risk and planning individual health-promoting interventions. The use of somatotype may be particularly useful given the known limitations of BMI, which does not differentiate between muscle and fat mass.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12872-025-05436-7. Introduction Cardiorespiratory fitness (CRF) is one of the strongest indicators of cardiovascular health and a predictor of death risk. Low CRF levels increase the likelihood of conditions such as hypertension [1], coronary heart disease [2, 3], stroke [4], arrhythmias, and heart failure [5]. In addition, people with low CRF have a higher risk of premature death compared to those with high CRF, regardless of other risk factors such as smoking, diabetes, hypertension, or high cholesterol [6–9]. Maximum oxygen uptake measured during dynamic exercise with increasing load until exhaustion (VO₂max) is recognised by the World Health Organization (WHO) as the best indicator of CRF [10]. Indeed, it is the only physiological indicator that integrates respiratory, cardiovascular, and working muscle functions into numerical values used to quantify the ability of the circulatory and respiratory systems to supply working muscles with oxygen and reflect the body’s ability to perform and tolerate physical activity [11]. Somatotype refers primarily to the morphological constitution of the whole human body. The determination of somatic constitution is used in sport, where somatic predisposition for different disciplines and competitions is analysed [12–14]. Although somatotyping has been recognized as a valuable anthropometric tool with potential applications beyond sports, it is still relatively seldom employed in health-related research [15–17]. A high proportion of endomorphic and mesomorphic components are associated with hypertension and liver disease [18], as well as an increased risk of coronary heart disease [19, 20]. Mesomorphy is linked to gastrointestinal diseases, neuroses, and lumbosacral spinal burden [21, 22]. Individuals with metabolic disorders such as type 2 diabetes have a higher proportion of endomorphic and mesomorphic components than healthy individuals, which is particularly evident in women [23]. Similarly, lean women with polycystic ovary syndrome (PCOS) have a higher proportion of the endomorphic component than their healthy peers [22]. On the other hand, somatotypes are not significantly associated with primary (28-day mortality) and secondary endpoints (hospital stay, intensive care unit [ICU] stay, and ventilator use duration) in critically ill surgical patients, despite the mesomorphic component being better at predicting these health outcomes [24, 25]. However, some studies have shown inconsistent or nonsignificant associations between somatotype and health-related biomarkers, indicating that the relationship may depend on the specific physiological or clinical outcomes examined. Furthermore, there were no differences in biochemical cardiovascular disease risk factors (glucose, cholesterol, and triglyceride levels) based on the somatotype of adult Malays [26]. The complexity and difficulty of performing cardiopulmonary function tests often restricts testing to cardiology offices, hospital wards, or research centres. As a result, most studies assessing treatment progress and health outcomes involve high-risk individuals or those undergoing medical procedures. In contrast, few studies include healthy people of all ages with low levels of physical activity who do not participate in sport. In addition, studies often relate CRF assessment solely to body weight or body composition, which does not always fully capture the complexity and multidimensionality of the relationship between CRF and body composition, and may be insufficient to assess CRF [27]. Therefore, the present study primarily aimed to assess CRF in adult men and women who declared low physical activity and determine its relationship with body composition. Materials and methods The measurement data of 276 adults, including 146 men and 130 women aged between 18 and 72, was collected and analysed as part of the “SMART - activity monitoring and workout rationalisation system” (number UDA-RPSL.01.02.00–24.00-045E/19 − 00) project, which obtained approval from the Institutional Ethics Committee of Academy of Physical Education in Katowice, number 8/2020. Volunteers were recruited from social media and individuals known to the research team. One of the inclusion criteria was the declared good health of the participants and the absence of chronic disease symptoms. The participant’s health status was confirmed by a physician during the initial examination. Individuals with diagnosed chronic conditions were excluded. Only individuals with a negative COVID-19 test result were included in the research procedures. Participants’ physical activity level was determined using the International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Global Physical Activity Questionnaire (GPAQ) [28]. The subjects had a weekly energy expenditure of less than 600 metabolic minute equivalents (MET-min/week), which categorised them as having low physical activity. Anthropometric measurements were taken using the methodology described by Martin and Saller (1957) [29]. These included height, body weight, skinfold thickness (at the shoulder, under the scapula, and above the hip plate), elbow epiphysis width, knee epiphysis width, arm circumference at rest and under tension, and calf circumference. Each subject also had their BMI (body mass index [kg/m2]) and WHR (waist-to-hip ratio) computed. Based on body measurements, regression equations were used to calculate the individual somatotype components according to the method of Sheldon (1940), as modified by Heath and Carter (1990) [30]. Next three main categories (endomorph, mesomorph, and ectomorph) were distinguished based on the predominant body type. After completing the measurements, the subjects underwent the Astrand-Ryhming fitness test to estimate VO₂max. Pre-test data collection included duplicate systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) measurements. During the test, applying constant loads helped maintain HR between 120 and 170 beats per minute, with HR monitored in real time using a Polar H10 chest belt. The trial used the step-test method, which consisted of climbing at a cadence of 22.5 climbs per minute, with a 33 cm step for women and a 40 cm step for men. An acoustic signal helped maintain pace. The average HR during the time in which the subject reached functional equilibrium was used to assess aerobic capacity. The VO₂max value was read from a nomogram [31], while the HR decrease rate was measured during the first, second, and third minutes of post-exercise restitution, and at the end of the trial. The data were analysed using Statistica 13.1. All analyses were performed separately for men and women. Since most of the biological traits studied were not normally distributed (the results of the Shapiro-Wilk and Kolmogorov-Smirnov tests indicated a significant deviation of the distributions of analysed traits from the normal distribution), the Kruskal-Wallis and Mann-Whitney tests were employed to assess the significance of differences between male and female traits and between variables characterising individuals with different somatotypes. To assess the strength and direction of the relationship between analysed groups, the effect size was employed using rg – Glass rank-biserial correlation coefficient effect size for Mann-Whitney test and ε2 – epsilon squared effect size coefficient for Kruskal-Wallis test. Post hoc tests were performed for multiple comparisons. Pearson’s correlation analysis evaluated the association between somatotypes and age in both sexes. Meanwhile, chi-squared (χ2) tests estimated the significance of differences in the prevalence of individual somatotypes in relation to sex. Results The somatotype was 4.58–5.03.58.03-1.89 in women, and 5.83-4.45.83.45-1.76 in men. Women were characterised by a significantly higher endomorphic component than men (Z = −5.86, p < 0.001). An inverse relationship was found for the mesomorphic component, with men achieving a greater proportion than women (Z = 3.64, p < 0.001), but there were no differences between sexes for the ectomorph component (Table 1). However, there was a marked difference in the prevalence of the main somatotypes based on sex (Table 2). The mesomorphic somatotype was predominant among men, whereas the endomorphic somatotype was most frequently observed in women (χ2 = 42.8; df = 2; p < 0.001). Table 1Somatotypes of Polish men and womenComponentMenWomenTestEffect size \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document} min-maxSD \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document} min-maxSDZ p r gEndomorphy 4.58 1.27–10.161.73 5.83 1.63–10.601.78−5.86< 0.001−0.408Mesomorphy 5.03 1.42–9.331.36 4.45 1.71–10.161.703.64< 0.0010.256Ectomorphy 1.89 0.10–4.831.15 1.76 0.10–4.731.190.910.3590.064 Somatotype 4.58–5.03.58.03-1.89 5.83-4.45.83.45-1.76 Table 1Somatotypes of Polish men and womenComponentMenWomenTestEffect size \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document} min-maxSD \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document} min-maxSDZ p r gEndomorphy 4.58 1.27–10.161.73 5.83 1.63–10.601.78−5.86< 0.001−0.408Mesomorphy 5.03 1.42–9.331.36 4.45 1.71–10.161.703.64< 0.0010.256Ectomorphy 1.89 0.10–4.831.15 1.76 0.10–4.731.190.910.3590.064 Somatotype 4.58–5.03.58.03-1.89 5.83-4.45.83.45-1.76 Somatotypes of Polish men and women Table 2Number and frequency of men and women according to somatotypeMenWomen n % n %Endomorph5436.999976.15Mesomorph7954.112620.00Ectomorph138.9053.85test χ242.8; df = 2; p < 0.001 Table 2Number and frequency of men and women according to somatotypeMenWomen n % n %Endomorph5436.999976.15Mesomorph7954.112620.00Ectomorph138.9053.85test χ242.8; df = 2; p < 0.001 Number and frequency of men and women according to somatotype Somatotype significantly differentiated BMI and waist circumference in women and BMI, waist circumference, and WHR in men (Table 3). Ectomorphs had the lowest values, while endo- and mesomorphs had similar magnitudes.Table 3Risk factors for low cardiovascular fitness in men and women with different somatotypesEndomorphMesomorphEctomorphEffect sizeEndomorphMesomorphEctomorphEffect size\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SDTest H/pε2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SDTest H/pε2MenWomenBMI [kg/m2]26.33.4525.83.1320.41.1233.2/<0.0010.22924.23.7224.23.7018.51.3512.9/0.0020.100WHR0.910.100.900.060.860.047.0/0.0300.0290.810.190.790.070.760.081.5/0.4770.017Waist circ. [cm]93.710.4190.09.6178.55.5025.7/<0.0010.17879.711.2577.39.3167.53.9110.0/0.0070.077HR at rest [beats/min]81.610.2278.111.8479.614.793.3/0.1900.02483.911.4579.98.8381.611.612.9/0.2400.022SBP at rest [mmHg]127.813.89125.412.57123.511.441.2/0.5530.008123.010.04120.613.25106.08.949.3/0.0090.073DBP at rest [mmHg]71.78.9368.87.6667.77.253.5/0.1750.02570.48.5266.47.0062.04.479.0/0.0110.071Peak HR during the test [beats/min]154.710.90150.118.85160.515.454.6/0.0990.033149.418.27151.911.77155.413.520.3/0.8530.003Mean HR during the test [beats/min]159.913.79146.715.69154.416.9721.1/<0.0010.146149.015.77142.319.03153.222.303.1/0.2140.024HR res in 1. min [beats/min]131.217.76116.219.63120.521.3417.1/<0.0010.118117.619.65109.525.63125.618.773.7/0.1530.029HR res in 2. min [beats/min]114.417.23101.916.18110.819.2117.7/<0.0010.122104.316.9997.622.15107.019.542.3/0.3220.018HR res in 3. min [beats/min]106.115.8995.414.81103.120.4216.1/<0.0010.11198.515.0592.918.81104.219.681.8/0.4170.014∆ HR res 1 – res 2 [beats/min]16.87.8414.38.269.85.2610.1/0.0060.07013.39.3811.97.6618.613.611.5/0.4740.012∆ HR res 2 – res 3 [beats/min]8.45.176.56.927.77.185.3/0.0710.0365.85.784.75.182.84.972.3/0.3240.017∆ HR res 1 – res 3 [beats/min]25.210.1820.810.2117.59.649.5/0.0080.06619.111.6016.610.1421.49.131.6/0.4590.012∆ HR mean – res 3 [beats/min]53.911.7251.310.6351.312.240.9/0.6260.00650.510.0249.59.1849.013.150.5/0.7750.004∆ HR rest – mean [beats/min]78.414.5668.314.8574.812.8113.4/0.0010.09665.215.9763.916.4671.617.290.8/0.6590.007VO2max [ml/kg− 1/min− 1]35.76.0939.88.9838.19.707.6/0.0220.05236.79.1341.912.9836.58.373.9/0.1410.030VO2max [l/min]3.10.623.20.782.60.9510.1/0.0060.0692.40.702.60.761.90.565.7/0.0500.044Legend: BMI body mass index [kg/m2], WHR waist-to-hip ratio, Waist circ. waist circumference [cm], HR at rest heart rate at rest [beats/min], SBP at rest systolic blood pressure at rest [mmHg], DBP at rest diastolic blood pressure at rest [mmHg], peak HR during the test - highest heart rate achieved during the test [beats/min]; mean HR during the test – mean heart rate achieved during the test [beats/min]; HR res in (1) min - decrease in heart rate during the first minute of post-test restitution [beats/min]; HR res in (2) min - decrease in heart rate during the second minute of post-test restitution [beats/min]; HR res in (3) min - decrease in heart rate during the third minute of post-test restitution [beats/min]; ∆ HR res 1 – res 2 - decrease in heart rate between first and second minutes of post-test restitution [beats/min]; ∆ HR res 2 – res 3 - decrease in heart rate between second and third minutes of post-test restitution [beats/min]; ∆ HR res 1 – res 3 - decrease in heart rate between first and third minutes of post-test restitution [beats/min]; ∆ HR mean – res 3 - decrease in heart rate between mean heart rate achieved during the test and three minutes of post-test restitution [beats/min]; ∆ HR rest – mean – difference in heart rate between resting heart rate before test and mean heart rate achieved during the test [beats/min]; VO2max maximal oxygen uptake, ε2 epsilon squared effect size coefficient for Kruskal-Wallis test Table 3Risk factors for low cardiovascular fitness in men and women with different somatotypesEndomorphMesomorphEctomorphEffect sizeEndomorphMesomorphEctomorphEffect size\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SDTest H/pε2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SD\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{X}$$\end{document}SDTest H/pε2MenWomenBMI [kg/m2]26.33.4525.83.1320.41.1233.2/<0.0010.22924.23.7224.23.7018.51.3512.9/0.0020.100WHR0.910.100.900.060.860.047.0/0.0300.0290.810.190.790.070.760.081.5/0.4770.017Waist circ. [cm]93.710.4190.09.6178.55.5025.7/<0.0010.17879.711.2577.39.3167.53.9110.0/0.0070.077HR at rest [beats/min]81.610.2278.111.8479.614.793.3/0.1900.02483.911.4579.98.8381.611.612.9/0.2400.022SBP at rest [mmHg]127.813.89125.412.57123.511.441.2/0.5530.008123.010.04120.613.25106.08.949.3/0.0090.073DBP at rest [mmHg]71.78.9368.87.6667.77.253.5/0.1750.02570.48.5266.47.0062.04.479.0/0.0110.071Peak HR during the test [beats/min]154.710.90150.118.85160.515.454.6/0.0990.033149.418.27151.911.77155.413.520.3/0.8530.003Mean HR during the test [beats/min]159.913.79146.715.69154.416.9721.1/<0.0010.146149.015.77142.319.03153.222.303.1/0.2140.024HR res in 1. min [beats/min]131.217.76116.219.63120.521.3417.1/<0.0010.118117.619.65109.525.63125.618.773.7/0.1530.029HR res in 2. min [beats/min]114.417.23101.916.18110.819.2117.7/<0.0010.122104.316.9997.622.15107.019.542.3/0.3220.018HR res in 3. min [beats/min]106.115.8995.414.81103.120.4216.1/<0.0010.11198.515.0592.918.81104.219.681.8/0.4170.014∆ HR res 1 – res 2 [beats/min]16.87.8414.38.269.85.2610.1/0.0060.07013.39.3811.97.6618.613.611.5/0.4740.012∆ HR res 2 – res 3 [beats/min]8.45.176.56.927.77.185.3/0.0710.0365.85.784.75.182.84.972.3/0.3240.017∆ HR res 1 – res 3 [beats/min]25.210.1820.810.2117.59.649.5/0.0080.06619.111.6016.610.1421.49.131.6/0.4590.012∆ HR mean – res 3 [beats/min]53.911.7251.310.6351.312.240.9/0.6260.00650.510.0249.59.1849.013.150.5/0.7750.004∆ HR rest – mean [beats/min]78.414.5668.314.8574.812.8113.4/0.0010.09665.215.9763.916.4671.617.290.8/0.6590.007VO2max [ml/kg− 1/min− 1]35.76.0939.88.9838.19.707.6/0.0220.05236.79.1341.912.9836.58.373.9/0.1410.030VO2max [l/min]3.10.623.20.782.60.9510.1/0.0060.0692.40.702.60.761.90.565.7/0.0500.044Legend: BMI body mass index [kg/m2], WHR waist-to-hip ratio, Waist circ. waist circumference [cm], HR at rest heart rate at rest [beats/min], SBP at rest systolic blood pressure at rest [mmHg], DBP at rest diastolic blood pressure at rest [mmHg], peak HR during the test - highest heart rate achieved during the test [beats/min]; mean HR during the test – mean heart rate achieved during the test [beats/min]; HR res in (1) min - decrease in heart rate during the first minute of post-test restitution [beats/min]; HR res in (2) min - decrease in heart rate during the second minute of post-test restitution [beats/min]; HR res in (3) min - decrease in heart rate during the third minute of post-test restitution [beats/min]; ∆ HR res 1 – res 2 - decrease in heart rate between first and second minutes of post-test restitution [beats/min]; ∆ HR res 2 – res 3 - decrease in heart rate between second and third minutes of post-test restitution [beats/min]; ∆ HR res 1 – res 3 - decrease in heart rate between first and third minutes of post-test restitution [beats/min]; ∆ HR mean – res 3 - decrease in heart rate between mean heart rate achieved during the test and three minutes of post-test restitution [beats/min]; ∆ HR rest – mean – difference in heart rate between resting heart rate before test and mean heart rate achieved during the test [beats/min]; VO2max maximal oxygen uptake, ε2 epsilon squared effect size coefficient for Kruskal-Wallis test Risk factors for low cardiovascular fitness in men and women with different somatotypes Legend: BMI body mass index [kg/m2], WHR waist-to-hip ratio, Waist circ. waist circumference [cm], HR at rest heart rate at rest [beats/min], SBP at rest systolic blood pressure at rest [mmHg], DBP at rest diastolic blood pressure at rest [mmHg], peak HR during the test - highest heart rate achieved during the test [beats/min]; mean HR during the test – mean heart rate achieved during the test [beats/min]; HR res in (1) min - decrease in heart rate during the first minute of post-test restitution [beats/min]; HR res in (2) min - decrease in heart rate during the second minute of post-test restitution [beats/min]; HR res in (3) min - decrease in heart rate during the third minute of post-test restitution [beats/min]; ∆ HR res 1 – res 2 - decrease in heart rate between first and second minutes of post-test restitution [beats/min]; ∆ HR res 2 – res 3 - decrease in heart rate between second and third minutes of post-test restitution [beats/min]; ∆ HR res 1 – res 3 - decrease in heart rate between first and third minutes of post-test restitution [beats/min]; ∆ HR mean – res 3 - decrease in heart rate between mean heart rate achieved during the test and three minutes of post-test restitution [beats/min]; ∆ HR rest – mean – difference in heart rate between resting heart rate before test and mean heart rate achieved during the test [beats/min]; VO2max maximal oxygen uptake, ε2 epsilon squared effect size coefficient for Kruskal-Wallis test In general, the CRF of the women showed no variation by body type, except for SBP and DBP at rest (Table 3). Ectomorphs had the lowest SBP and DBP values, while endomorphs had the highest. Estimated CRF and VO2max were highest in the mesomorph group, while ectomorphs had the lowest aerobic ceiling. For men, somatotype differentiated the results achieved in the Astrand-Ryhming test, with mesomorphic men achieving the lowest HR during the test and each post-test assessment. The men also differed in the size of the increase in HR during exercise (highest increase in endomorphs and lowest in mesomorphs) and the rate of return to baseline HR (slower decline in mesomorphs). Estimated CRF and VO2max were significantly highest in male mesomorphs (Table 3; Fig. 1).Fig. 1Medians, quartiles and min-max ranges of VO2max in men and women with various somatotypes. P values for post-hoc comparisons indicate significant differences Medians, quartiles and min-max ranges of VO2max in men and women with various somatotypes. P values for post-hoc comparisons indicate significant differences In both sexes, VO2max showed significant correlations with somatotype components (Table 4). CRF deteriorated with increasing endomorphy and ectomorphy, while CRF improved with an increase in the mesomorphic component. Relative BMI positively influenced VO2max (l/min), while VO2max (ml/kg/min) significantly correlated with WHR in men, indicating an association between greater abdominal fat accumulation and worsened CRF (Table 4). Table 4Relationship between maximal oxygen uptake and measures of body composition (Pearson’s r correlation coefficients)VO2max [ml/kg/min]VO2max [l/min]MenWomenMenWomenBMI [kg/m2]−0.13−0.20*0.41***0.31***WHR−0.20*0.100.020.13Waist circ. [cm]−0.21*−1.18*0.32***0.24**Endomorphy−0.28**−0.36***0.120.07Mesomorphy−0.03−0.170.31***0.17*Ectomorphy0.090.16−0.31***−0.24**BMI body mass index, WHR waist-to-hip ratio, Waist circ. waist circumference [cm]* p < 0.05; ** p < 0.01; *** p < 0.001 - Level of significance Table 4Relationship between maximal oxygen uptake and measures of body composition (Pearson’s r correlation coefficients)VO2max [ml/kg/min]VO2max [l/min]MenWomenMenWomenBMI [kg/m2]−0.13−0.20*0.41***0.31***WHR−0.20*0.100.020.13Waist circ. [cm]−0.21*−1.18*0.32***0.24**Endomorphy−0.28**−0.36***0.120.07Mesomorphy−0.03−0.170.31***0.17*Ectomorphy0.090.16−0.31***−0.24**BMI body mass index, WHR waist-to-hip ratio, Waist circ. waist circumference [cm]* p < 0.05; ** p < 0.01; *** p < 0.001 - Level of significance Relationship between maximal oxygen uptake and measures of body composition (Pearson’s r correlation coefficients) BMI body mass index, WHR waist-to-hip ratio, Waist circ. waist circumference [cm] * p < 0.05; ** p < 0.01; *** p < 0.001 - Level of significance Discussion The results of the present study confirm that somatotype significantly differentiates the level of CRF, as assessed by VO₂max, in men and women. This phenomenon is consistent with numerous reports showing that VO₂max is an indicator of physical fitness, as well as a strong predictor of cardiovascular disease, metabolic disease, and overall mortality risk, regardless of sex and ethnicity [32–36]. Sui et al. (2020) and Mandsager et al. (2018) showed that higher VO₂max is associated with longer life expectancy [35, 37]. In contrast, reduced VO₂max values were observed in men with increased depressive symptoms [38, 39], and were also linked to a threefold higher risk of transient cerebral ischaemic episode [40]. Studies have shown that higher CRF levels are associated with a lower risk of lung cancer [38, 41], breast cancer [42, 43], and colorectal cancer [44]. Importantly, recent large-scale evidence further supports that improving CRF over time lowers mortality risk across age, sex and disease strata [36], and the American Heart Association recommends routine clinical assessment of CRF as a “clinical vital sign” [34]. In the context of the data mentioned above, the results of the present study provide interesting observations. In women, the highest VO₂max values (in ml·kg⁻¹·min⁻¹) were observed in the mesomorphic group, while the lowest were observed in the ectomorphic group. Similarly, the highest levels of VO₂max (in ml·kg⁻¹·min⁻¹ and in L·min⁻¹) were achieved by male mesomorphs. These results suggest that the mesomorphy component, associated with a greater proportion of muscle mass, promotes higher aerobic capacity. This may be due to greater active muscle mass, responsible for oxygen uptake during exercise, and more favourable haemodynamic parameters, such as lower HR during exercise and faster post-exercise restitution, which was also confirmed in the male group in this study. Mechanistically, this may reflect greater active muscle mass (higher mitochondrial volume density and oxidative enzyme capacity), improved stroke volume and peripheral oxygen extraction, and more favorable hemodynamic responses (lower HR during exercise and faster post-exercise restitution), which we also observed in men in this study [32, 45–47]. For this reason, the limitations of BMI as a measure of health risk are being increasingly highlighted. Indeed, BMI, as an index of body mass in relation to body height, does not distinguish between muscle and fat mass [48, 49]. People with comparable BMIs may have markedly different body compositions, which carry diverse health consequences. For example, mesomorphs with a higher BMI may be more protected from metabolic risk than those with the same BMI and a predominant endomorphy, involving a higher proportion of body fat, particularly visceral fat [49]. Recent studies using bioelectrical impedance and modern somatotype stratification confirm strong links between somatotype, muscle–fat distribution and metabolic profile, reinforcing the added value of somatotyping beyond BMI alone [50, 51]. Overweight and obese individuals are characterised by poorer cardiovascular parameters (including increased SBP and DBP) [52, 53], metabolic disorders (e.g., type 2 diabetes) [54, 55, 56], shortened life expectancy, and increased morbidity and mortality from various causes [57, 58–59]. Dose-response meta-analyses further demonstrate graded associations of central adiposity with incident hypertension and diabetes, supporting our interpretation of endomorphic risk [52, 54]. In general, in both sexes, the somatotypes shown in the present study significantly differentiated the basic anthropometric parameters (BMI, WHR, waist circumference) known to be risk factors for health disorders associated with excessive fat mass; endomorphy was associated with higher measurement values and ectomorphy with the lowest [60]. These morphological gradients are concordant with our functional findings (CRF differences by somatotype), strengthening the internal coherence of the results. The results indicate that somatotype significantly differentiates blood pressure at rest. As expected, the highest systolic and diastolic blood pressure values were recorded in predominantly endomorphic subjects, while the lowest values were recorded in predominantly ectomorphic subjects. The gradients were particularly evident in the female group, where they reached a level of statistical significance. These results are consistent with the observations of other authors, who also showed a positive correlation between endomorphy and SBP and DBP values, and a negative correlation between these parameters and ectomorphy [61, 62]. Herrera et al. [62] observed a statistically significant relationship between a higher proportion of endomorphy and elevated blood pressure among older women, while Malina et al. confirmed a similar trend among the adult population, particularly females [61]. HR, measured immediately after the Astrand-Ryhming test, showed no real differentiation by somatotype. However, the combination of higher resting BP in endomorphs with lower CRF (in ml·kg⁻¹·min⁻¹) underscores a convergent risk profile that merits attention in preventive practice. VO2max is used to determine the level of permissible workload in healthy people and the permissible training load during sports and rehabilitation training [10, 63]. The level of VO₂max can be measured directly during maximal exercise or calculated from the HR during submaximal efforts, such as the Astrand-Ryhming test. This test uses the linear relationship between exercise-induced HR increase and oxygen uptake [63]. Assessing somatotype before an exercise test can help identify individuals at increased risk of an abnormal haemodynamic response [64]. Moreover, maintaining or improving CRF has been shown to reduce mortality risk independent of BMI status, highlighting the pragmatic value of targeting fitness alongside body composition [36, 65, 66]. The present study had several limitations that could affect the observed relationship between somatotype and CRF. Firstly, the study group was characterised by inactivity or low levels of physical activity. Since this was assessed subjectively and people tend to overestimate their activity levels (Schaller et al., 2016), it can be assumed that nobody in the participant group was actively engaged in sports [67]. Additionally, recruitment via social media may introduce self-selection bias, potentially limiting external generalizability. Secondly, one of the inclusion criteria was good health and no obvious symptoms of chronic diseases. Although the health status of each participant was assessed by a physician at the time of the initial examination, it was not possible to avoid the participation of those with previously undiagnosed diseases, such as hypertension or metabolic disorders. Therefore, it is impossible to state whether or not undiagnosed and untreated hypertension, for example, had an impact on the lower cardiorespiratory performance in the Astrand test. Thirdly, as a cross-sectional study, our design precludes causal inference regarding the directionality of associations between somatotype and CRF. However, the same relationship between CRF and body composition is also observed among unhealthy people and shows a similar direction as the present study [65, 66]. In addition, the study was conducted during the coronavirus disease 2019 (COVID-19) pandemic, making it difficult to perform additional functional and laboratory tests before the exercise test, which could have identified those with a cardiovascular burden. For safety reasons, testing protocols were reduced as much as possible. Nonetheless, COVID-19 tests, a medical examination, and standardized questionnaires — the International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Global Physical Activity Questionnaire (GPAQ) [28] — made it possible to exclude individuals with potential respiratory and cardiovascular consequences of previous COVID-19 infections. Conclusions Somatotype provides a more complete morphological description of the individual and allows for a better interpretation of results related to physical performance and health risk. Indeed, the present study showed that somatotype differentiated anthropometric parameters, VO₂max values, and haemodynamic responses to exercise, which may have important implications for chronic disease risk assessment. The introduction of somatotype analysis into routine diagnostics can be a valuable complement to classical indicators such as BMI, allowing for a more accurate assessment of health status and personalisation of physical activity recommendations. Supplementary Information Supplementary Material 1. Supplementary Material 1.